0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Splenomegaly in Thyrotoxicosis

Samuel P. Marynick, MD
JAMA. 1982;247(20):2782. doi:10.1001/jama.1982.03320450020022.
Text Size: A A A
Published online

To the Editor.—  Edward R. Eichner, MD, and Charles L. Whitfield, MD, presented an excellent algorithmic approach to the diagnosis of splenomegaly (1981;246:2858). However, there is one omission that strikes an endocrinologist immediately: thyrotoxicosis. In the article by Baldridge and Peterson (1927;88:1701) they describe 144 patients with exopthalmic goiter, of which 44 had palpable spleens. Other authors have reported the induction of lymphoid hyperplasia and splenomegaly by thyroxine in experimental animals.1,2In the 73 patients I have seen with thyrotoxicosis, there have been three with generalized prominent lymphadenopathy that resolved after correction of the thyrotoxicosis. Two of the 73 had easily palpable splenomegaly as well as thrombocytopenia and leukopenia, a syndrome previously reported.3 One of the two with decreased platelets had undergone a splenectomy before it was discovered he had thyrotoxicosis. Splenomegaly resolved in the second patient when a euthyroid state was achieved following sodium iodide I 131

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();